| Company/Division name | BrainStorm Cell Therapeutics Inc. |
| Parent company | BrainStorm Cell Therapeutics Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | Israel |
| City reshored to: | Boston |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Under-utilized capacity |
